Robert Koch Institute

Germany Reports First Case of Mpox Variant Ib Amid Ongoing Health Monitoring

Germany reports its first case of the mpox variant Ib, confirmed by the Robert Koch Institute (RKI). While health authorities monitor the situation closely, they assure the public that there is no immediate increased risk. The emergence of this more contagious variant, previously declared a global health emergency by WHO, raises concerns about potential transmission and severity of mpox. Current vaccines are believed to be effective against clade I viruses. Stay informed as health officials navigate this evolving public health challenge.